Cargando…
Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alpha
Glaucoma, a neurodegenerative disease, is currently being treated by modulation of one of its primary risk factors, the elevated intraocular pressure. Newer therapies that can provide direct neuroprotection to retinal ganglion cells are being extensively investigated. Tumor necrosis factor-α, a cyto...
Autores principales: | Agarwal, Renu, Agarwal, Puneet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442458/ https://www.ncbi.nlm.nih.gov/pubmed/22824592 http://dx.doi.org/10.4103/0301-4738.98700 |
Ejemplares similares
-
The Role of Mitophagy in Glaucomatous Neurodegeneration
por: Stavropoulos, Dimitrios, et al.
Publicado: (2023) -
Astrocyte Networks as Therapeutic Targets in Glaucomatous Neurodegeneration
por: Boal, Andrew M., et al.
Publicado: (2021) -
The Neurovascular Unit in Glaucomatous Neurodegeneration
por: Wareham, Lauren K., et al.
Publicado: (2020) -
Current Concepts in the Biochemical Mechanisms of Glaucomatous Neurodegeneration
por: Shoeb Ahmad, Syed, et al.
Publicado: (2013) -
Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration
por: Al Hussein Al Awamlh, Sara, et al.
Publicado: (2021)